TAP2 and COVID-19: C Expression patterns varied across disease severity levels: CR1 showed the highest expression in severe COVID-19 cases and the lowest in healthy individuals, while TAP2 was most highly expressed in healthy samples and lowest in mild COVID-19 cases (Figure 6D).